Benefortin Flavour 2.5 mg Tablets for Cats and Dogs

Страна: Великобритания

Язык: английский

Источник: VMD (Veterinary Medicines Directorate)

Активный ингредиент:

Benazepril Hydrochloride

Доступна с:

Lavet Pharmaceuticals Ltd

код АТС:

QC09AA07

ИНН (Международная Имя):

Benazepril Hydrochloride

Фармацевтическая форма:

Tablet

Тип рецепта:

POM-V - Prescription Only Medicine – Veterinarian

Терапевтическая группа:

Cats, Dogs

Терапевтические области:

Cardio Vascular ACE inhibitor

Статус Авторизация:

Authorized

Дата Авторизация:

2012-01-25

Характеристики продукта

Revised: June 2020
AN: 00221/2020
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Benefortin Flavour 2.5 mg tablets for cats and dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE Benazepril hydrochloride: 2.5 mg(equivalent to
Benazepril 2.30 mg)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Brownish, oval, divisible, tablet scored on both sides. The tablets
can be divided into equal
halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Dogs:
Treatment of congestive heart failure.
Cats:
Reduction of proteinuria associated with chronic kidney disease.
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
Do not use in cases of hypotension, hypovolaemia, hyponatraemia or
acute renal failure.
Do not use in cases of cardiac output failure due to aortic or
pulmonary stenosis.
Do not use during pregnancy or lactation (section 4.7).
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: June 2020
AN: 00221/2020
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
No evidence of renal toxicity of the veterinary medicinal product has
been observed (in
dogs or cats) during clinical trials, however, as is routine in cases
of chronic kidney
disease, it is recommended to monitor plasma creatinine, urea and
erythrocyte counts
during therapy. The efficacy and safety of benazepril has not been
established in dogs and
cats below 2.5 kg body weight.
The chewable tablets are flavoured. In order to avoid any accidental
ingestion, store
tablets out of reach of the animals.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Wash hands after use.
In case of accidental oral ingestion, seek medical advice immediately
and show the label or
the package leaflet to the physician.
Pregnant women should ta